2021
September 20, 2021
SAN CARLOS, California, September 20, 2021 — Galaxy Medical announced today the initiation of the SPACE-AF study with enrollment of the first two patients at Southlake Regional Health Centre in Newmarket, Canada. In the study, the CENTAURI Pulsed Electric Field (PEF) ablation system will be used to ablate both the pulmonary veins and posterior walls in patients with persistent atrial fibrillation (AF).... MORE
July 28, 2021
SAN CARLOS, California, July 28, 2021 — Galaxy Medical announced today that the ECLIPSE-AF
90-day remapping data, presented at the Stanford BioDesign New Arrhythmia Technologies retreat, demonstrated durable lesions and chronic pulmonary vein isolation (PVI). Also, the company has recently treated patients in the same study using CE-Marked catheters and mapping systems from Boston Scientific, Biosense Webster and Abbott.... MORE
July 22, 2021
SAN CARLOS, California, July 22, 2021 — Galaxy Medical announced today that the 90 day remapping results of its ECLIPSE-AF study will be featured at the 2021 Stanford Biodesign New Arrhythmia Technologies Retreat on July 27th. Ante Ani, M.D., Electrophysiology Laboratory Director at University Clinical Hospital in Split, Croatia, and primary investigator of the study will deliver the presentation.... MORE
June 15, 2021
JUNE 15, 2021 / 4PM EST - SESSION 3 (3-PART WEBINAR SERIES)
Advanced PEF - The Nuance / Focused On Pulsed Electric Field Technology
- The Evidence for Cardiac Sync
- Microbubbles
- Tissue Recovery
- Does Contact Matter?
- Tissue Planes: The Unique Feature of PEF
May 24, 2021
MAY 24, 2021 / 5PM EST - SESSION 2 (3-PART WEBINAR SERIES)
Applying PEF - The Execution / Focused On Pulsed Electric Field Technology
- Basics on Titrating Treatment Effect by Increasing Efield, or Changing Effective Lethal Threshold
- Waveform Characteristics
- Monophasic vs. Biphasic
- Adjusting the “Knobs” to Optimize Dose
- Monopolar vs. Bipolar
- Single-shot vs. Focal
April 30, 2021
APRIL 30, 2021 / 5PM EST - SESSION 1 (3-PART WEBINAR SERIES)
PEF Basics - The Science / Focused On Pulsed Electric Field Technology
- Charging Cells
- Cell Injury & Death
- Evolution of PEF Myocardial Injury
- Tissue Specific Responses
April 22, 2021
SAN CARLOS, California, April 22, 2021 — Galaxy Medical announced today that the acute results of its Europe-focused ECLIPSE-AF study will be featured during the upcoming EHRA Congress in a innovative Technology presentation on April 25th by Ante Ani , M.D., Electrophysiology Laboratory Director at University Clinical Hospital in Split, Croatia, and primary investigator of the study.... MORE
April 6, 2021
SAN CARLOS, California, April 6, 2021 — Galaxy Medical (Galaxy) and Japan Lifeline (JLL) today announced an exclusive distribution agreement for the ALPHA1 ablation catheter in the United States, developed by Japan Lifeline for use with the Galaxy CENTAURI™ Pulsed Electric Field (PEF) System. Under the terms of the agreement, Galaxy will pursue US regulatory approval for ALPHA1 in support of eventual commercialization of the CENTAURI PEF System.... MORE
March 16, 2021
SAN CARLOS, California, March 16, 2021 — ATP, a leader in life science venture capital, announced today $18M in Series A financing for its portfolio company Galaxy Medical, Inc. The funds are being used to advance the development of Galaxy’s flagship product CENTAURI™, which uses Pulsed Electric Field (PEF) technology... MORE
January 18, 2021
SAN CARLOS, Calif., Jan. 18, 2021 — Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that its proprietary CENTAURI™ System will be featured in a recorded case presentation on Sunday January 31st during the upcoming AF Symposium... MORE